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TIiE production of nitric oxide (NO) was measured
in cultures of spleen cells stimulated by lipopoly-
saccharide (LPS), IL-2 or LPS + IL-2. We observed
that NO synthesis is increased by IFN-1( but inhib-
ited by IFN-/. This is not the case when IL-2 is
present in the cultures, since interferons play a
minor role in the regulation of the NO produc-
tion. When IL-2 and LPS were associated in the
cultures, the IFN-/ role seems more important
than that of IFN-/. PGE2 inhibits NO production in
LPS supplemented cultures but has a slight effect
in the presence of IL-2 and no effect with IL-2 +
LPS. 3-isoButyl-l-methylxanthine OBMX), an inhi-
bitor of phosphodiesterases, induces a decrease of
IFN production. In the presence of H-7, an inhi-
bitor of protein kinase C (PKC), NO production is
reduced when the cultures are supplemented by
LPS or IL-2 but not when IL-2 and LPS are both
added. H-7 also reduced IFN production. In the
presence of Na-monomethyl-L-arginine (N-MMA),
an inhibitor of NO synthesis, IFN production was
increased, with no change in the cytotoxic
activity. Hence, interferons regulate NO produc-
tion by mouse spleen cells and, in return, NO
modulates the generation of IFN.
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Nitric oxide (NO) is important in many biolo-
gical functions. It is generated from L-arginine by
the enzyme NO synthase (NOS). Peritoneal mac-
rophages of mice are the best-characterized
source of NO.
LPS and interferonq, (IFNq,) constitute the
major stimulating factors of NO production
2 by
increasing cellular concentrations of NOS. Many
functions of LPS have been reported to be medi-
ated by prostaglandin production, which in turn
acts by increasing cAMP.4’5 The role of PGE2 on
NO production is unclear. PGE2 did not affect
NO production nor did it inhibit NO produc-
tion. Other work shows that NO activates
cyclooxygenase enzymes and leads to a marked
increase in PGE2 production.
8
IntraceLlular mechanisms induced by LPS impli-
cate protein kinase C (PKC) and cAMP depen-
dent protein kinase A. LPS causes the
translocation of protein kinase C from cytosol to
the membrane.9 PKC has been involved in the
induction of NO synthase activity in macrophages
by IFNq,.
1 Another report suggested rather the
role of protein kinase A.
The studies on NO production and NO regula-
tion have been performed essentially with purl-
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fled macrophage populations. We have shown in
previous work that LAK activity induced by IL-2
was reduced by LPS and that the decrease was
related to the increase of IFN-cz/[3 production.
2
On the other hand, NO was implicated in LAK
activity in rodents. Thus the aim of this study
was to evaluate NO production induced by
splenic macrophage cultures with other splenic
cell populations and their cytokines after stimula-
tion by LPS and IL-2, and to assess if there is a
relationship between the generation of cytotoxic
activity and NO production.
We have investigated whether NO, measured
as nitrite (NO-), is detected in supernatants of
spleen cells stimulated for 3 days in the presence
of LPS, IL-2 or LPS + IL-2, and the role played
by interferons induced by IL-2 and LPS on NO
generation. We have also examined whether NO
production was regulated by PGE2 and by LPS-
induced PKC activation. Finally we have investi-
gated whether NO plays a role in the generation
of cytotoxic activity.
Materials and Methods
Mice: Inbred C3H mice, 6-8 weeks old, were
used throughout the experiments.
(C) 1996 Rapid Science PublishersNO, absence of implication in cytotoxic activity induced by LPS
Reagents.. Lipopolysaccharide from Escherichia Spontaneous release was obtained by incubating
coli 055:B5 was purchased from Difco. Anti-IFN- targets alone and total release was determined by
a/3 serum (1:320000) was a generous gift from collecting 1001.tl from cells in which the pellet
Dr Ion Gresser (IRCS, Villejuif, France). Anti- had been resuspended. All assays were per-
murine IFN-T antibodies were purchased from formed in triplicate. The S.E.M. of the mean was
Genzyme (Boston, MA). rlL-2 was purchased within 5-10% and was not represented. Results
from Cetus Corporation (Emeryville, CA) and of cytotoxicity assays were expressed either in
PGE2, IBMX, N-MMA and H-7 from Sigma (St percent of lysis for different effector/target cell
Louis, MO). ratios or in lytic units (LU)/107 cells. LU was cal-
culated from linear regression curves plotted
Cell lines.. YAC-1 and L929 cells were maintained from the various E/T ratios. One LU was defined
in vitro. YAC-1 is a Moloney virus-induced lym- as the number of effector cells required to lyse
phoma of A/Sn origin. L929 is a fibroblast cell 20% of the target cells.
line derived from an adult C3H mouse.
IFN assay: The presence of IFN was assayed by
Preparation of spleen cells.. Spleen cells were anti-vesicular stomatitis virus (VSV) activity. L929
harvested and suspended in phosphate- cells were seeded in 96-well (3 x 104/well) fiat-
microtitre plates. Serial dilutions of supernatants buffered saline solution (PBS). Erythrocytes were
removed by osmotic shock and the final cell were added. After 18h at 37C, the cells were
suspension was resuspended in RPMI 1640 infected with VSV at high multiplicity of infection.
culture medium supplemented with 5% foetal The plates were scored after 24h. The antiviral
calf serum, t-glutamine (2 mM), Hepes (10 mM), effect was estimated by measuring the incorpora-
penicillin (100 U/ml), streptomycin sulfate tion of red neutral dye into living cells according
(100btg/ml), and 2-mercaptoethanol (0.05mM), to the method described by Hudson and Hay
5
which constitutes complete medium, and using a Titertek multiscan spectro-
photometer. The IFN titre of a supernatant was
estimated as the reciprocal of the dilution inhi- Measurement of NO production: NO was
estimated by measuring the formation of NO- biting 50% of the cytopathic effect.
(the stable oxidative end product of NO) which
serves as a quantitative index of macrophage u*
activation. NO- levels in culture fluids were
estimated by using the Griess reagent.
4 Briefly, Release ofNO in spleen cells cultured in the pre-
1001.tl culture fluid was incubated with an equal sence ofLPS, IL-2 or LPS + IL-2: Initially we tried
volume of 1% sulfanilamide and 1% N-l-naphthy- to determine whether under our experimental
lethylenediamine dihydrochloride in 2.5% H3PO4 conditions, splenocytes could be stimulated by
(Sigma) at room temperature for 5 min. NO- IL-2, LPS or both, to produce NO. For that
was quantified by using spectrophotometry to purpose spleen cells were cultured for 3 days in
the presence of increasing concentrations of the measure the OD at 570nm, with NaNO2 as a
standard, inducers used either alone or associated. NO-
was assessed in supernatants by the Griess pro-
Inhibition ofNO synthesis.. The specific inhi- cedure. The results of one out of three similar
bitor of NO synthase, A-monomethyl--arginine experiments are shown in Fig. 1. We observed
that the response to LPS was induced with low (N-NMA) was added at a concentration of 50 l.tM
to the spleen cell culture.
Cytotoxicity as_say: Effector spleen cells were
assayed using 51Cr-Na2CrO4-1abelled (Amersham,
UK) target cells. Cells from the YAC line were
used as targets. Cytotoxic activity was measured
concentrations of reagent (lng/ml), increased
and reached a plateau for a range of concentra-
tions from 100 to 10000ng/ml. NO induction
was possible with 100 U/ml of IL-2, and was even
greater when LPS and IL-2 were present in the
culture. One should underline that even if IL-2
alone at 10 U/ml did not induce NO synthesis it for different spleen/target cell ratios in a final can act synergistically with LPS. volume of 2001al. After 4h incubation at 37C, In a previous report
12 it was demonstrated that 100btl supernatants were removed from each
well for counting. Specific lysis was calculated
as:
experimental release- spontaneous release
% lysis x 100
total release spontaneous release
IL-2-induced LAK activity was diminished by LPS
(1 l.tg/ml). As the aim of this work was to investi-
gate whether NO production was involved in that
decrease, the following experiments were per-
formed with 1000U/ml of IL-2 and 1 l.tg/ml of
LPS.
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FIG. 1. Production of NO in supernatant of spleen cells cultured
for 72 h with various concentrations of LPS, IL-2 or with LPS +
IL-2. The data are expressed as the mean from one representa-
tive experiment performed in triplicate (S.E.M. < 10%). @,
Medium; I, IL-2, lOU/ml; A, IL-2, lOOU/ml; x, IL-2, lO00U/
ml.
Implication of interferons in the production of
nitric oxide: IL-2 is an inducer of IFNq,.16 LPS is
also an inducer of IFN-a/[3 and the association
of IL-2 with LPS induces a synergistic increase in
the production of IFN-a/[ and IFN-/. 12’18 More-
over, IFN-a/[ is implicated in the change in cyto-
toxic activity induced by LPS on IL-2-stimulated
spleen cells.
12
We have studied the effects of IFNq, or IFN-a/
on NO production induced by LPS after 72 h
of culture. For this purpose 100 U/ml of IFNq, or
IFN-a/ were added to spleen cells cultured in
the presence of LPS at 1 l.tg/ml. Table 1 sum-
marizes four experiments. It was observed that
IFNq, induced an increase of NO- (+ 128%)
while IFN-t/13 reduced NO- production
(-- 34%).
We then determined if the interferons induced
by LPS, IL-2 or a mixture of both played a role in
NO production. For that, the culture was incu-
bated in the presence of anti-IFN-2 antibodies or
anti-IFN-a/13 anti-serum, and NO- was measured
after 3 days. Table 2 presents the results of three
Table 2. NO variation (in percent) induced in presence of anti-
IFN-( or IFN-/[ antibodies in murine spleen cell cultured with
LPS, IL-2 or LPS + IL-2
Experiment Substance(s) NO variation (%)
added
anti-IFN- anti-IFN-/[3
LPS 50 + 62
IL-2 9 +11
LPS + IL-2 13 + 39
LPS 78 + 48
IL-2 0 0
LPS + IL-2 26 + 38
LPS 43 + 30
IL-2 0 + 10
LPS + IL-2 15 + 39
aResults were presented as the percentage of variation (enhancement or
inhibition) induced by anti-IFN-, or anti-IFN-/ presence and calculated
as A--B/B x 100, in which A is NO measured in the anti-IFN cultures
and B is NO measured in cultures without anti-IFN.
experiments. We observed that for LPS cultures
the anti-IFNq, antibodies reduced NO produc-
tion. This effect of anti-IFN-2 antibodies was
diminished in cultures stimulated by IL-2 or IL-2
+ LPS. The presence of anti-IFN-a/[ serum
increased NO production by 40% for LPS and IL-
2 + LPS cultures, with smaller increases in IL-2
cultures.
The role of cAMP on NO production by spleen
cells cultured in the presence of IL-2 or IL-2 +
LPS, in relation to IFN production: LPS-stimu-
lated macrophages produce PGE2 which induces
a transient increase of cAMP production. cAMP
is degraded by phosphodiesterases. For testing
the effects of endogenous PGE2 stimulated by
LPS, we added IBMX, an inhibitor of phospho-
diesterase, to the cultures and therefore pro-
moted the accumulation of cAMP in the culture
medium. NO production was measured after 3
days. Results were presented as the percent varia-
tion of NO between the IBMX group and the
untreated group. The percent variation of five
experiments is shown in Table 3. The produc-
Table 1. Effects of IFN-/I or IFN-( on NO production by
spleen cells cultured 72 h with LPS
Experiment Concentration of NO- (nmol/ml)
LPS LPS + IFN-/a LPS + IFN-/
8 31 5
2 10 22 6
3 15 30 10
4 17 31 12
Mean _+ S.E.M. 12.5 ___
2.1 28.5 +/- 2.0
b 8.2 +/- 1.9
aSpleen cells were cultured for 72 h with LPS (1 btg/ml) added or not,
with IFN-, or IFN-/ at 100 U/ml.
bp < 0.01 VS. LPS.
Cp < 0.05 vs. LPS.
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Table 3. Effect of a phosphodiesterases inhibitor (IBMX) on the
NO produced by LPS, IL-2 or LPS + IL-2 stimulated spleen cells
cultured for 3 days
Experiment NO variation (%)a
LPS L-2 LPS + L-2
73 32 21
2 80 +23 36
3 58 50 9
4 74 33 39
5 92 10 +25
Mean +/- S.E.M. -75.4+/-5.5 -20.4+/- 12.6 16.2+/- 11
a% variation A-B/B x 100 in which A is NO measured in IBMX
culture (100 lg/ml) and B is NO measured in culture without IBMX.NO, absence of implication in cytotoxic activity induced by LPS
Table 4. Effect of H-7 presence on the NO produced by spleen








LPS IL-2 LPS + IL-2
65 70 6
75 62 13
64 54 + 9
--68 62 +4
68.0___2.5 -62.0___3.3 1.5-1-4.9
a% variation A- B/B x 100 in which A is NO measured in H-7 culture
(20 pM) and B is NO measured in culture without H-7.
-10 -9 -8 -7 -6
PGE2 (log of molar concentration)
FIG. 2. Effect of PGE2 in the NO produced after 3 days culture of
spleen cells stimulated by LPS (1 lg/ml), IL-2 (lO00U/ml) or
both. The data are expressed as the mean from one representa-
tive experiment performed in triplicate (S.E.M. < 10%). , LPS;
[], IL-2; A, LPS + IL-2.
tion of NO was inhibited when IBMX was
present in LPS-stimulated cultures (--75%), and
much less for IL-2 or IL-2 + LPS stimulated cul-
tures, -20% and -16%, respectively. LPS seems
to induce cAMP accumulation since the presence
of IBMX corresponded to NO inhibition, but it
seems that it was not secondary to PGE2 induc-
tion. Indeed, when the cultures were incubated
in the presence of indomethacin, NO production
was reduced similarly to that in cells cultured
without indomethacin (data not shown).
The addition of IBMX produced a fall of IFN
production. The IFN level (which was, respec-
tively, 29-+_ 15 and 180 48U/ml for IL-2 and
LPS + IL-2 cultures) fell to 3.5 +_ 0.8 and
5 +_ 2 U/ml when the cultures were incubated in
the presence of IBMX.
We have evaluated the effects of exogenous
PGE2 on NO production in spleen cell cultures
with IL-2 or LPS alone, or in combination. The
results of one experiment out of three are shown
in Fig. 2. PGE2 concentrations as low as 10-9M
inhibit NO production induced by LPS alone
(-73%). This effect is less important with IL-2
(--10%). PGE2 does not significantly modify NO
production in cultures containing IL-2 + LPS;
even at a final concentration of 10-M the
decrease is only 5%.
Effect ofa PKC inhibitor on NO and IFNproduc-
tion: The potential involvement of PKC in the
signal transduction pathway by which LPS/IFNq,
induces NO synthesis in macrophages was .sug-
10 gested by Severn et al. IL-2/receptor interaction
produces 9 a redistribution of PKC. Experiments
were undertaken to ascertain the role of PKC in
the formation of NO and IFN as induced by
stimulation of spleen cells by LPS, IL-2 or LPS +
IL-2. The spleen cells were cultured in presence
or absence of H-7, an inhibitor of PKC.
NO production was measured after 3 days of
culture and the percent variation of NO for four
experiments is presented in Table 4. It was
observed that H-7 induced a similar inhibition of
approximately 65% for the cultures stimulated
with LPS or IL-2. No inhibition was observed for
cultures stimulated by LPS + IL-2. The produc-
tion of IFN was inhibited by 86 _+ 10% in the
presence of H-7 for IL-2 cultures and 96 __+ 2%
for LPS + IL-2 cultures (mean of three experi-
ments S.E.M.).
Role of NO in the generation of IAK cells and
IFN production: We have found NO production
by spleen cells cultured with LPS, IL-2 or IL-2 +
LPS. We have examined if NO is involved in the
generation of cytotoxic cells of the LAK type and
in IFN production. In these experiments NO,
which is derived from a terminal guanidino nitro-
gen from a_r{.inine, is blocked by the -arginine
analogue N-monomethyl arginine (N-MMA).
Spleen cells were cultured for 3 days with LPS
(1 lag/ml), It-2 (1000 U/ml) or It-2 + LPS in pre-
sence or absence of N-MMA (50 btM).
NO and IFN levels were measured in the super-
natants and the cells were collected and tested for
their cytotoxic activity against YAC cells for differ-
ent effector-target cell ratios (10:1 to 0.15:1).
Cytotoxic activity was expressed in lytic units.
Results of four experiments are reported in
Table 5.
We observed that the production of NO falls
in the presence of N-MMA, while IFN production
was always increased. There was a non-significant
trend for cytotoxic activity to increase in the pre-
sence of N-MMA.
Discussion
We have examined NO production in murine
spleen cell cultures stimulated with either LPS, IL-
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Table 5. The effects of N-MMA presence on NO- and IFN production and generation of cytotoxic activity in spleen cells cultured for 3
days with LPS (1 lg/ml), IL-2 (1000 U/ml) or IL-2 + LPS
Experiment Substance(s) NO- (nmol/ml) IFN (U/ml) Cytotoxic activity (LU)
added
Without With Without With Without With
N-MMA /V-MMA N-MMA N-MMA N-MMA N-MMA
LPS 10 2 12 14 51 60
IL-2 13 5 18 29 500 667
IL-2 + LPS 23 5 139 192 138 166
2 LPS 20 3 2 72 75
IL-2 20 3 11 83 625 1190
IL-2 + LPS 25 5 125 322 312 480
3 LPS 11 3 5 ND ND
IL-2 9 21 34 1049 1250
IL-2 + LPS 23 2 153 256 232 312
LPS 15 ND ND ND ND
IL-2 13 13 15 1000 1050
IL-2 + LPS 23 100 1421 285 222
aLU lytic units calculated at 20% cytotoxicity/10 cells.
bN-MMA 50M.
ND, not done.
2 or LPS + IL-2 for 3 days. We observed similar
NO production in cultures containing IL-2 and in
those containing LPS. It is known that only LPS
and IFNq, are stimulating factors of NO produc-
tion by macrophages.
2 The NO induced in the
IL-2-stimulated spleen cell cultures was probably
attributable to IFNq, induced by IL-2.16 The pro-
duction of NO was significantly increased when
LPS and IL-2 were combined in the cultures.
LPS induced low levels of IFN. The association
of IL-2 with LPS induced a synergy in IFN pro-
duction.12’18 Similarly to the work of Ding et al.
2
in macrophage cultures, we observed that IFNq,
increases the NO induced by LPS in spleen cell
cultures but different effects were obseeeed with
IFN-a/[ addition. In the latter, we observed a sig-
nifican reduction of NO production, whereas
Ding et al. observed that IFN- or IFN- alone
were not inductors of NO, but their association
with LPS increased NO production although to a
lesser degree than IFNq,.
This opposing effect that we have observed,
depending upon the type of IFN added to LPS,
was confirmed when spleen cells were cultured
in the presence of either anti-IFN-2 antibodies or
anti-IFN-/[ serum. When the cultures were
made in the presence of anti-IFNq, antibodies,
we observed (Table 2) a reduction of NO
induced by LPS and to a lesser degree by LPS +
IL-2, but there was no effect on IL-2 cultures. In
the presence of anti-IFN-a/[ serum a similar
increase of NO was observed in LPS or LPS +
IL-2 culture and a lower increase for IL-2 cul-
tures. This result differed from that of Riches and
Underwood
2 who found that the anti-IFN-a/[
presence inhibited the NO release by macro-
phages stimulated by IFN-2 and poly IC.
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Thus, IFN-a/]3 has immunomodulatory proper-
ties which differ from those of IFN-7 for the
modulation of NO production. Different effects
of these two types of IFN have been described
21 for induction of IL-1; induction of cytotoxic
activity
2 and ConA and IL-2-induced proliferation
of spleen T-cells.
22
If IFN-, is an inducer of NO, it must be
emphasized that NO is an inhibitor of IFN pro-
duction. Indeed when the cultures were made in
presence of an inhibitor of NO, IFN production
was increased.
We observe that independent of the stimulat-
ing agent, the reduction of NO by N-MMA was
followed by a small increase in cytotoxic activity
in nine of ten cytotoxic assays (Table 5). In con-
trast with our results, Juretic et a1.13 reported that
reduction of NO production induced a decrease
of LAK activity in rodent spleen cells. At present,
we do not have an explanation for this dis-
crepancy.
The increase of IFN production and the weak
effect on cytotoxic activity in cultures made in
the presence of an inhibitor of NO may be sec-
ondar to a reduction of PGE2. Indeed Salvemini
et al. have shown that PGE2 production was
associated with NO production which activates
cyclooxygenase enzymes. So we hypothesize that
the fall of NO induced a reduction of PGE2,
which explains the increase of IFN. PGE2 is
known to be an inhibitor of IFN production
23
and cytotoxic activity generation.
24
In our system LPS induced PGE2 because (a)
IFN production and cytotoxic activity were
increased in the presence of indomethacin,
which is an inhibitor of cyclooxygenase
pathway;
12 and (b) IBMX which produces aNO, absence of implication in cytotoxic activity induced by LPS
cAMP accumulation inhibits NO production
(Table 4). On the other hand exogenous PGE2
inhibits NO induced by LPS (Fig. 2). Unexpect-
edly, the presence of indomethacin which should
provoke an increase of NO synthesis by inhibi-
tion of PGE2 production, caused a slight
decrease of NO production. A similar effect was
observed by Schleifer and Mansfield.25 So cAMP
accumulation in the presence of IBMX was not
necessarily related to a PGE2 effect. This is in
agreement with the data of Piguet-Pellorce and
Dy2 who reported that the increase in histamine
release by bone marrow cells stimulated by LPS
plus GM-CSF, was related to an increase of
cAMP, which is not related to PGE2 synthesis. In
contrast, PGE2 can increase NO production by
LPS-stimulated Kuppfer cells.27 In IL-2 or IL-2 +
LPS cultures, the presence of IBMX reduced NO
production, although the inhibition was less than
in LPS culture; however, IFN production was
drastically reduced. On the other hand PGE2
induced a slight but significant reduction of NO
in IL-2 cultures, but we did not observe a PGE2
effect in LPS + IL-2 cultures. This suggests that
IL-2 or IL-2 + LPS induce the release of factors
which counterbalance the inhibitory effect of
PGE2. Moreover IL-2 has been reported to partly
reverse the inhibitory effect of PGE2.28
The signal transduction pathway by which IFN-
3’ induces NO production remains to be estab-
lished. PKC is involved in the induction of nitric
oxide synthase by IFN-3,, protein kinase C activ-
ity is increased by IFN-, but not by IFN-cz/]3 or
LPS.29 Work by Fujihara et a/.3 showed that PKC
plays an important role in the LPS-triggered
signal transduction pathway. However, other dif-
ferent protein kinases such as PKA via PGE2
induction may be involved. There is also a link
between PKA-mediated signalling and nitric oxide
synthase.
11 Using H-7, an inhibitor of PKC, we
observed a similar reduction of NO that is
induced by LPS or IL-2. No effect was observed
when the cells were cultured in the presence of
IL-2 + LPS, but the presence of H-7 induced a
large reduction (97%) of IFN induced by LPS +
IL-2. Gessani et al.3 showed that treatment of
macrophages by staurosporine, an inhibitor of
PKC, stimulated by IFN-3t inhibits IFN secretion.
There is a relationship between intracellular
cAMP concentration and PKC activation.32 H-7
was an inhibitor of PKC and also of PKA. One
might hypothesize that the inhibition of NO
induced by H-7 may correspond to the PKA inhi-
bition of LPS, and the PKC inhibition of IL-2.
H-7 did not affect NO production in LPS + IL-
2 culture but reduced IFN production. It must be
emphasized that inhibition of PKC may involve
the reduction of the inhibitors of NO production
such as TGF-33’34 and/or IL-4.5’ On the other
hand, as we have shown, it may be that IFN-cz/J3
plays an inhibitory role in NO production, and
the fall of IFN-0t/[3 might explain the main-
tainance of NO levels.
We underline that two metabolic inhibitors, i.e.
IBMX and H-7, which did not affect the NO level,
reduced IFN production in IL-2 + LPS cultures,
whereas N-MMA, which inhibited NO production,
increased IFN levels.
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